Author:
A Azzabi1, O Mahfoudh1, N Ben Aicha1, W Sahtout1, A Ayadi2, Z Lajmi3, M Smida4, H Chouaieb4, M Chatti4, S Ismail4, R Boukadida1, F Sabri 1, S Ben Amor1, D Zellama1, S Hmissa3, H Kochtali2, A Fathallah4*, Y Guedri1, A Achour1
Author address:
1Department of Nephrology, Sahloul University Hospital, Sousse, Tunisia
2Department of Maxillofacial Surgery, Sahloul University Hospital, Sousse, Tunisia
3Department of Anatomical and Cellular Pathology, Sahloul University Hospital, Sousse, Tunisia
4Department of Parasitology Mycology, Farhat Hached University Hospital, Sousse, Tunisia
Full conference title:
10th Advances Against Aspergillosis and Mucormycosis
Date: 2 February 2022
Abstract:
Introduction:
Mucormycosis is a rare but devastating mycotic infection. Cutaneous mucormycosis is less common than other clinical forms, but potentially lethal if treatment is not rapid.
Purpose:
We present the case of cutaneous mucormycosis in a kidney transplant patient with fatal outcome.
Case report:
A 38-year-old patient presented to the Emergency Department with fever and a lower right jugal ulcerated lesion following a skin irritation. His past history gives a kidney transplant in 2019, uncontrolled diabetes type 2 and tuberculous pleurisy in 2017. After a 2 days stay in the emergency room, the patient was admitted in Nephrology Department. Massive debridement was performed. Histopathologic examination and mycologic culture confirmed the diagnosis of mucormycosis. The patient died two days after admission.
Conclusion:
Mucormycosis is a rare but fatal mycotic infection. Cutaneous mucormycosis is less common than other clinical forms, but potentially lethal if treatment is not timely started.
Abstract Number: 19
Conference Year: 2022
Link to conference website: https://aaam2022.org/
URL Conference abstract: